Trial intelligence / Profile preview

Predicting Post Extubation Stridor in Patients With Intermaxillary Fixation

NCT05839756Recruiting

Sponsor
Mansoura University
Start
May 2023
Primary completion
Feb 2028
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised trial of budesonide in post-extubation stridor (PES) and laryngeal edema (2 arms), sponsored by Mansoura University. Primary endpoint: Laryngeal air column width ratio. Started May 2023; status: recruiting.

02

Drugs

budesonide
03

Conditions

post-extubation stridor (PES)laryngeal edema

Beyond the preview

Go deeper on NCT05839756.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05839756.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call